» Prosensa update on regulatory discussions and ongoing plans for re-dosing Action Duchenne: "Prosensa today provided an update to the patient-led organisations. They have been encouraged in their discussions with the regulatory authorities and are on-track for a pathway forward by the end of June.
The team also informed us that they are also on-track for re-dosing in the first group of boys in the third quarter of this year. Re-dosing is taking a staged approach, under new or existing treatment protocols or via expanded access programs. In a first wave, they will initiate re-dosing at sites in both US and Europe and as stated previously are actively working with these sites and investigators to execute these plans."
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment